Ofloxacin Oral Suspension

Ofloxacin Oral Suspension belongs to the Suspensions category within the Antibiotics, Infectious Diseases, and Pediatric Care therapeutic segments. It is a second-generation fluoroquinolone with broad-spectrum antibacterial activity.

For pharmaceutical marketing companies, this is a high-prescription antibiotic product with consistent demand. Saar Biotech manufactures it from our manufacturing facility in Baddi.

At Saar Biotech, we manufacture Ofloxacin Suspension using a controlled oral suspension manufacturing process that ensures dose uniformity, palatability, and packaging reliability.

• API Uniformity: Ofloxacin is uniformly suspended for consistent dosing.
• Taste Masking: Mango and mixed fruit flavours mask the bitter taste.
• pH and Stability Management: The active remains chemically stable for 24 months.
• 30ml and 60ml Pack Coverage: Suitable for pediatric and adult treatment courses.

This suspension is manufactured and supplied by Saar Biotech for the following established clinical indications:

• Respiratory Tract Infections: Acute bronchitis, pneumonia, sinusitis
• Urinary Tract Infections: Cystitis, pyelonephritis
• Gastrointestinal Infections: Bacterial diarrhoea, gastroenteritis
• Skin and Soft Tissue Infections: Bacterial skin infections
• Ear Infections: Otitis media, otitis externa

Schedule H — Requires valid medical prescription.

Ofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and transcription, leading to bacterial cell death.

Manufacturing Integrity

• Suspension Uniformity: Ofloxacin is uniformly suspended for consistent dosing.
• pH Stability: The suspension vehicle is pH-buffered to maintain active stability.

Saar Biotech provides Third-Party Manufacturing for Ofloxacin Suspension from our oral suspension manufacturing facility in Baddi, Himachal Pradesh.

• Facility: Oral suspension manufacturing area with controlled processing, automated bottle filling, capping, labelling, and carton packing lines.
• Capacity: Scalable from brand-entry launches to large commercial batches.
• Quality Lab: In-house GLP-certified lab with HPLC assay, pH, viscosity, MLT, and fill volume checks.
• Turnaround: New orders — 30 to 45 working days. Repeat orders — 20 to 25 working days.
• Packaging: 30ml and 60ml PET or dark amber bottles; sticker label, metallic label, measuring cup, printed cap.
• MOQ: Starting at 5,000–10,000 units per SKU.

1. Warehouse Conditions: Store below 30°C in a cool, dry environment. Do not freeze.
2. Shake Well Before Every Dose: Critical for uniform API distribution.
3. Measuring Cup Use: A calibrated measuring cup ensures accurate dosing.
4. Light Protection: Dark amber bottles and outer cartons protect from light-induced degradation.

Every commercial batch is quarantined until it passes a comprehensive analytical release protocol:

• HPLC Assay: Quantification of Ofloxacin 50mg per 5ml.
• Suspension Uniformity: Sediment behaviour and re-dispersibility testing.
• pH & Viscosity Testing: Suspension stability monitoring.
• Microbial Limit Testing (MLT): IP-compliant microbiological testing.
• Certificate of Analysis (COA): Issued with every B2B batch.

• Arthropathy Risk: Ofloxacin not recommended for children under 18 years except specific indications.
• Tendon Disorders: Risk of tendonitis and tendon rupture; discontinue if pain occurs.
• Contraindications: Hypersensitivity to fluoroquinolones; pregnancy and lactation.

For third-party manufacturing enquiries, private-label contracts, or to request pricing and packaging options for Ofloxacin Suspension, please use the B2B enquiry form below.